Beam Therapeutics
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.
5
Funding Rounds
$689.0m
Money raised
Overview
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.
-
Websites:
- Business model: B2B B2C
- Headquarters: Cambridge, Massachusetts
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Da*** R. Li* |
|
- | |
| J. Ke*** Jo*** |
|
- | |
| Fe** Zh*** | - | - |
Funding
Funding series
Funding Series Analysis
The company Beam Therapeutics has raised a total of $554m in funding over 5 rounds.
Key Insights:
- Beam Therapeutics Venture round, January 19, 2021: $260m
- Beam Therapeutics Venture round, February 11, 2020: $207m
- Beam Therapeutics Series A round, May 2018: $87m
- Beam Therapeutics Inc. funding round, March 2019: $135m
Beam Therapeutics Venture round, January 19, 2021
$260m
Beam Therapeutics Venture round, February 11, 2020
$207m
Beam Therapeutics Series A round, May 2018
$87m
Beam Therapeutics Inc. funding round, March 2019
$135m
Industries
Beam Therapeutics is active in the following industries: